Literature DB >> 10820170

Course of renal injury in the Mpv17-deficient transgenic mouse.

Thomas O'Bryan1, Hans Weiher2, Helmut G Rennke3, Stefan Kren1, Thomas H Hostetter1.   

Abstract

The mutant Mpv17 mouse is a transgenic strain that fails to express a protein that is normally expressed in the kidney and that is associated with peroxisomes. The present studies provide a quantitative examination of renal function and structure in this strain compared to its control CFW strain. By 52 wk of age, the mutant strain developed proteinuria (urinary protein to creatinine ratio: 25 +/- 14 versus 3 +/- 1, mutant versus control), albuminuria (urinary albumin to creatinine ratio: 23 +/- 15 versus 0.1 +/- 0.1, mutant versus control), and hypoalbuminemia (2.1 +/- 0.4 versus 2.5 +/- 0.2 G/dl, mutant versus control), but without arterial hypertension or major reduction in filtration (serum creatinine 0.14 +/- 0.04 versus 0.18 +/- 0.12 mg/dl, mutant versus control). The Mpv17 glomeruli were enlarged (0.98 +/- 0.12 versus 0.52 +/- 0.02 micrometer(3) x 10(6), mutant versus control). Glomerular sclerosis became widespread (95 +/- 3 versus 23 +/- 32%, mutant versus control) and was preceded by mesangiolysis and microaneurysms. Tubulointerstitial disease was conspicuous by its absence. The intrarenal vasculature was normal in the mutant mice. Electron microscopy demonstrated focal foot process fusion and mesangiolysis. Thus, this mutant strain of mouse develops proteinuria and a distinct glomerulopathy including mesangiolysis but little interstitial injury all due to the loss of expression of a single gene.

Entities:  

Mesh:

Year:  2000        PMID: 10820170     DOI: 10.1681/ASN.V1161067

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  11 in total

1.  Prkdc participates in mitochondrial genome maintenance and prevents Adriamycin-induced nephropathy in mice.

Authors:  Natalia Papeta; Zongyu Zheng; Eric A Schon; Sonja Brosel; Mehmet M Altintas; Samih H Nasr; Jochen Reiser; Vivette D D'Agati; Ali G Gharavi
Journal:  J Clin Invest       Date:  2010-10-18       Impact factor: 14.808

2.  Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease.

Authors:  K A Nath; J P Grande; J J Haggard; A J Croatt; Z S Katusic; A Solovey; R P Hebbel
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

3.  Abnormal basement membrane in the inner ear and the kidney of the Mpv17-/- mouse strain: ultrastructural and immunohistochemical investigations.

Authors:  Angela M Meyer zum Gottesberge; Heidi Felix
Journal:  Histochem Cell Biol       Date:  2005-07-26       Impact factor: 4.304

4.  Safety and biocompatibility of carbohydrate-functionalized polyanhydride nanoparticles.

Authors:  Julia E Vela-Ramirez; Jonathan T Goodman; Paola M Boggiatto; Rajarshi Roychoudhury; Nicola L B Pohl; Jesse M Hostetter; Michael J Wannemuehler; Balaji Narasimhan
Journal:  AAPS J       Date:  2014-11-25       Impact factor: 4.009

5.  MicroRNAs are potential therapeutic targets in fibrosing kidney disease: lessons from animal models.

Authors:  Jeremy S Duffield; Monica Grafals; Didier Portilla
Journal:  Drug Discov Today Dis Models       Date:  2013

6.  Mpv17 in mitochondria protects podocytes against mitochondrial dysfunction and apoptosis in vivo and in vitro.

Authors:  Gabriela Casalena; Stefanie Krick; Ilse Daehn; Liping Yu; Wenjun Ju; Shaolin Shi; Su-yi Tsai; Vivette D'Agati; Maja Lindenmeyer; Clemens D Cohen; Detlef Schlondorff; Erwin P Bottinger
Journal:  Am J Physiol Renal Physiol       Date:  2014-03-05

Review 7.  MicroRNAs as potential therapeutic targets in kidney disease.

Authors:  Ivan G Gomez; Monica Grafals; Didier Portilla; Jeremy S Duffield
Journal:  J Formos Med Assoc       Date:  2013-02-04       Impact factor: 3.282

Review 8.  Implementing large-scale ENU mutagenesis screens in North America.

Authors:  Amander T Clark; Daniel Goldowitz; Joseph S Takahashi; Martha Hotz Vitaterna; Sandra M Siepka; Luanne L Peters; Wayne N Frankel; George A Carlson; Janet Rossant; Joseph H Nadeau; Monica J Justice
Journal:  Genetica       Date:  2004-09       Impact factor: 1.082

9.  A monoclonal antibody raised against bacterially expressed MPV17 sequences shows peroxisomal, endosomal and lysosomal localisation in U2OS cells.

Authors:  Hans Weiher; Haymo Pircher; Pidder Jansen-Dürr; Silke Hegenbarth; Percy Knolle; Silke Grunau; Miia Vapola; J Kalervo Hiltunen; Ralf M Zwacka; Elmon Schmelzer; Kerstin Reumann; Hans Will
Journal:  BMC Res Notes       Date:  2016-02-27

10.  Early-onset liver mtDNA depletion and late-onset proteinuric nephropathy in Mpv17 knockout mice.

Authors:  Carlo Viscomi; Antonella Spinazzola; Marco Maggioni; Erika Fernandez-Vizarra; Valeria Massa; Claudio Pagano; Roberto Vettor; Marina Mora; Massimo Zeviani
Journal:  Hum Mol Genet       Date:  2008-09-24       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.